Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Venus Remedies Ltd.    VENUSREM   INE411B01019

VENUS REMEDIES LTD.

 (VENUSREM)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Venus Remedies Ltd. : Venus wins Manufacturing Leadership Award 2012 more...

09/18/2012| 04:12am US/Eastern
Recommend:
0

18th September, 2012

Venus wins Manufacturing Leadership Award 2012

Venus Remedies Limited has won Manufacturing Leadership Award for its world class manufacturing and operational excellence at the "Industry 2.0 Manufacturing Innovation Conclave 2012".
Such award functions are testaments to the skills, ingenuity and vision of the creators. Being in the highly regulated Pharmaceutical industry, Venus's three manufacturing facilities has 15 national and international GMP certifications to its credit, which includes EU-GMP, WHO-GMP, GCC-GMP, Latin American GMP (INVIMA) and many more. The company has marked itself in the niche segment of `Critical care' in antibiotic, oncology, neurology and cardiovascular, so, manufacturing excellence is the basic minimum at Venus. This award shall motivate the company to achieve further heights in producing high quality medicines at the lowest possible costs in order to preserve and improve the human life.
Venus Remedies Limited, a name in the few research based Indian pharmaceutical companies with 3 units in Panchkula; Baddi (India) and Werne (Germany), and 9 manufacturing facilities with injectable capacity of 80mn and a product kitty of 75 products. Venus is among the top 10 players globally in injectables space with only 1% of India's over 10,000 pharmaceutical companies into the injectable segment. Besides this, Venus has come up with some revolutionary products, for which the company has filed more than 360 patents worldwide and already bagged 80 patents including patents from USA, Europe, Japan, Australia and other countries. Manufacturing excellence enable commercialization of the patented products into revenue. During 2011-12 around 25% of Venus revenue comes from the research products and near 10% from the regulated markets. These statistics are further validation of our manufacturing excellence.
The company has invested in state-of-the-art laboratories equipped with sophisticated equipments and facility systems compliant with CFR and capable of generating audit trails. Venus adheres to the stringent quality control norms benchmarked with global GMP standards, thereby leading to international product quality. Thus making the company a suitable partner for strategic alliances with domestic and global pharmaceutical giants.
Manufacturing leaders are truly the masters of all trades, dealing with multiple, complex and interlinked issues ranging from people management to automation, risk management to innovation and optimization to collaboration. Multiple awards were given under the various categories and were open for the entire manufacturing community in India. The award function "Industry 2.0 Manufacturing Innovation Conclave 2012" was instituted and organised by Industry 2.0 magazine, a publication of 9.9 Media on 14 th September, 2012 at The Grand Hyatt, Mumbai. The awards seek to recognize exceptional initiative, pioneered manufacturing breakthroughs, developed best practices, and nurtured exceptional teams to deliver manufacturing excellence. The Industry 2.0 Manufacturing Leadership Awards encompass all areas of manufacturing, including strategy, operational excellence, innovation, supply chain improvement, environmental management, technology deployment and human resource development.

Apart from this, Venus Remedies has won 'Silver Certificate of Merit' in the Economie Times' India Manufacturing Excellence Awards (IMEA), 2011 in recognition and acknowledgment of Venus's high standards in terms of its manufacturing practices, quality, regulatory approvals, significant investment on its state-of-the-art R&D centre, well equipped facilities and fine infrastructure.

distributed by
Recommend :
0
Partner Area
React to this article
 
Latest news on VENUS REMEDIES LTD.
1d ago VENUS REMEDIES LTD.: Venus Remedies gets Mexico patent for Potentox more...
05/06 VENUS REMEDIES LTD.: ELORES awarded Gold Medal for being the best Innovation of..
03/12 VENUS REMEDIES LTD.: Venus Remedies’ MEROPENEM receives market authorization in..
02/25 VENUS REMEDIES LTD.: Venus sign Exclusive Marketing Rights deal for its novel A..
02/15 VENUS REMEDIES LTD.: Venus Remedies bags Australian GMP from TGA for four of it..
01/18 VENUS REMEDIES LTD.: Venus Remedies launches ‘ELORES’ - CSE 1034 a US patent pr..
2012 VENUS REMEDIES LTD.: Venus Gets Phase III Nod for Its Cancer Detection NCE more..
2012 VENUS REMEDIES LTD.: VENUS GETS PHASE III NOD FOR ITS CANCER DETECTION NCE more..
2012 VENUS REMEDIES LTD.: ex-dividend day for annual dividend
2012 VENUS REMEDIES LTD.: Venus wins Manufacturing Leadership Award 2012 more...
Advertisement
Chart
Duration : Period :
Venus Remedies Ltd. Technical Analysis Chart | VENUSREM | INE411B01019 | 4-Traders
Income Statement Evolution
Venus Remedies Ltd. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.